Tumor-growth-promoting cyclooxygenase-2 prostaglandin E2 pathway provides medulloblastoma therapeutic targets
about
Cytomegalovirus in human brain tumors: Role in pathogenesis and potential treatment optionsG-protein coupled receptor expression patterns delineate medulloblastoma subgroupsEstablishment and characterization of an orthotopic patient-derived Group 3 medulloblastoma model for preclinical drug evaluation.Docosahexaenoic acid metabolome in neural tumors: identification of cytotoxic intermediates.Celecoxib suppresses the phosphorylation of STAT3 protein and can enhance the radiosensitivity of medulloblastoma-derived cancer stem-like cells.Identification and development of mPGES-1 inhibitors: where we are at?Autocrine prostaglandin E2 signaling promotes tumor cell survival and proliferation in childhood neuroblastoma.Detection of human cytomegalovirus in medulloblastomas reveals a potential therapeutic targetMight salicylate exert benefits against childhood cancer?COX/mPGES-1/PGE2 pathway depicts an inflammatory-dependent high-risk neuroblastoma subset.Prostaglandins in cancer cell adhesion, migration, and invasionA standardized and reproducible protocol for serum-free monolayer culturing of primary paediatric brain tumours to be utilized for therapeutic assays.Wnt/β-catenin pathway regulates MGMT gene expression in cancer and inhibition of Wnt signalling prevents chemoresistanceNADPH oxidase NOX5-S and nuclear factor κB1 mediate acid-induced microsomal prostaglandin E synthase-1 expression in Barrett's esophageal adenocarcinoma cells.The rationale for targeted therapies in medulloblastoma.mPGES-1 as a target for cancer suppression: A comprehensive invited review "Phospholipase A2 and lipid mediators".Is human cytomegalovirus a target in cancer therapy?Therapeutic implications of disorders of cell death signalling: membranes, micro-environment, and eicosanoid and docosanoid metabolismA contemporary review of molecular candidates for the development and treatment of childhood medulloblastoma.Inhibitors of microsomal prostaglandin E2 synthase-1 enzyme as emerging anti-inflammatory candidates.Anticancer activity of tolfenamic acid in medulloblastoma: a preclinical study.Frequent detection of human cytomegalovirus in neuroblastoma: a novel therapeutic target?Celecoxib enhances radiosensitivity in medulloblastoma-derived CD133-positive cells.Omega-3 fatty acid supplementation delays the progression of neuroblastoma in vivo.Intermolecular cross-talk between the prostaglandin E2 receptor (EP)3 of subtype and thromboxane A(2) receptor signalling in human erythroleukaemic cells.Targeting the hedgehog signal transduction pathway at the level of GLI inhibits neuroblastoma cell growth in vitro and in vivo.Response to tumor necrosis factor-α mediated inflammation involving activation of prostaglandin E2 and Wnt signaling in nucleus pulposus cells.Inhibition of Microsomal Prostaglandin E Synthase-1 in Cancer-Associated Fibroblasts Suppresses Neuroblastoma Tumor Growth.
P2860
Q26996612-F55CF08E-F6E6-41EC-BF48-F19169FD3138Q28302285-6A07B96C-3680-4BC2-AD93-D0AC9FD540CAQ33572502-B1BFC623-7B62-48EF-AAD4-3AC3965C88FFQ33694562-BCBB7BAB-4591-4D2B-8117-76A20CFD4861Q33907955-89FDB69B-138A-4F89-AD25-4BB6918627E2Q34056458-A161DACD-803D-4C7A-B204-C18C6F765D75Q34140169-51FC9DDD-AA70-4D38-B129-DB67919F616CQ35370135-37BBCE9F-293E-4FF1-A448-001BB28B0813Q35602134-40483D60-FAF1-4C66-A36A-B8B309C03F4EQ35818767-35DE8983-F590-464B-8A6D-D8B673BF1136Q35821653-C50A3760-6665-47EA-AB1B-3D90C62499CBQ35860191-91F3220C-C479-4823-A399-96204D65CA35Q36361024-7975540D-EE89-487C-A189-74368DB2DBBBQ36776711-7EFD3BCA-DCF8-480B-BBCE-8F2DBECC387DQ37409736-94B9A46B-B960-42B6-91A1-6FE3A2B903BFQ37693270-A402118B-A22C-4B45-8FC0-8E516524D2D5Q37975925-BF395EB9-6FD5-4DF9-850E-A42C82F4A60DQ37988008-A631A11C-6595-4820-BB26-166D1596C5E2Q38071943-182C0C61-90C7-48DC-88AB-E036AFE51738Q38229056-D47E0D30-BD24-41BF-A276-D2BB0C2318C6Q39149869-F058D10D-7080-4332-ACC9-D127488239FAQ39153890-F0BD3068-EFF0-4352-9F9C-6108F0626045Q39696393-2C42BC87-0299-45A2-B9E2-53A880DB1070Q39700720-8E2F1984-431B-44B4-870D-C412B897391EQ39809132-66C5DF3C-5A87-4C0B-9BA7-D471483D633BQ50786723-931BA3BC-1E28-4FB0-ADA3-00CD86821A0EQ53448192-DE449584-BB1D-498B-8108-48F6C743C4C4Q55429085-A2B34F3D-BE8C-448C-B406-83F8B7473F71
P2860
Tumor-growth-promoting cyclooxygenase-2 prostaglandin E2 pathway provides medulloblastoma therapeutic targets
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 August 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Tumor-growth-promoting cycloox ...... loblastoma therapeutic targets
@en
Tumor-growth-promoting cycloox ...... oblastoma therapeutic targets.
@nl
type
label
Tumor-growth-promoting cycloox ...... loblastoma therapeutic targets
@en
Tumor-growth-promoting cycloox ...... oblastoma therapeutic targets.
@nl
prefLabel
Tumor-growth-promoting cycloox ...... loblastoma therapeutic targets
@en
Tumor-growth-promoting cycloox ...... oblastoma therapeutic targets.
@nl
P2093
P2860
P1433
P1476
Tumor-growth-promoting cycloox ...... loblastoma therapeutic targets
@en
P2093
Abiel Orrego
Baldur Sveinbjörnsson
Bengt Gustavsson
Bertil Kågedal
Carl Otto Oqvist
John Inge Johnsen
Lova Segerström
Ninib Baryawno
Per Kogner
Staffan Eksborg
P2860
P304
P356
10.1215/15228517-2008-035
P577
2008-08-20T00:00:00Z